SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
about
Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcomaGenomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumorsGermline mutation of INI1/SMARCB1 in familial schwannomatosisEpithelioid Sarcoma: Opportunities for Biology-Driven Targeted TherapyUpdate from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base.Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitorsRapid detection of SMARCB1 sequence variation using high resolution melting.Oncogenic roles of SMARCB1/INI1 and its deficient tumorsEmbryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers.deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.Polycomb and trithorax opposition in development and disease.SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.Epithelioid finger-sarcoma in an 11 year old girl--a case report.Epithelioid sarcoma: one institution's experience with a rare sarcomaConsistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor.The role of genetics in the establishment and maintenance of the epigenome.Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling.Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis.Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumorsOssifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma.Targeting the absence: homozygous DNA deletions as immutable signposts for cancer therapy.Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.Newly Described Tumor Entities in Sinonasal Tract Pathology.Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.Proximal-type epithelioid sarcoma--a rare, aggressive subtype of epithelioid sarcoma presenting as a recurrent perineal mass in a middle-aged maleSwi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promotersPoly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcomaA comparative genomic approach for identifying synthetic lethal interactions in human cancer.Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.Proximal-type Epithelioid Sarcoma of the Head and Neck (HN): A Study with Immunohistochemical and Molecular Analysis of SMARCB1.Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
P2860
Q21245750-6A5EEC4B-26A3-4FA4-82BF-763A5E3D8EAAQ24643365-EA195C95-7E60-4E2D-93AE-5AA711315DBEQ24682982-3286A8A4-E1EF-4F74-B089-49DD831DB3C0Q26782730-41AA4CC4-B04D-42A5-A18A-A5FBBF46AA5BQ30253069-B72D903D-E10C-41FD-B59A-E2C52B09EB72Q30497840-19E392BD-E07B-4018-BD41-F90F85D37744Q33409828-350474F7-101B-4DFC-A814-8F0B4DFB3977Q33517967-CBE67C6E-2F69-47FD-A949-6F9E4C331A42Q33607443-F8220B2E-E0C7-430F-9F8F-43B3FA5D3F30Q33798328-52024DFF-6556-4B19-973A-4B38855263A3Q33916606-A651DFC1-6DF6-482F-9B88-0BFD96B88BFFQ33920032-24F9F23A-A4D6-4D27-9A67-BE942B66D065Q34052714-FA849B6B-B6FB-48CA-B462-8F3DF85786E4Q34131210-75883156-581F-403A-8E76-C755B499AA49Q34265480-F4BB8691-1590-414C-A987-234850F44015Q34483391-D8166619-0C43-40AB-8EC1-93CA22D23DFBQ34486393-A926BAB4-D067-435A-B8F3-82B467897026Q34627709-EC20578A-B40F-4A1A-B7E5-AD0AE082935CQ34649133-53D37F2E-59A6-4C53-A5E7-0507E7EF7885Q34682098-D56EE3B1-1E5C-41D1-80CE-82B65468C550Q34915348-49032082-E22A-4246-AB84-E4C28AA71455Q34981535-F935E1FD-7679-4760-933A-384F1B1A051FQ34997153-465CA030-AD23-4948-BCE2-4B7285E945A4Q35035462-5E93A538-5357-42D5-BCA4-30BB0B0DFFDDQ35350535-D7953B75-40C1-4078-BB09-984FBACB35E7Q35584579-9FAA782C-BE37-4C7F-AC38-BBC4BEB30B96Q35953149-8F5E2D60-B11E-4802-802D-CA8EAFE8ED7DQ36002501-3D84439B-1C47-4BA4-9B06-3AF807C18D5DQ36480578-858C5340-0BDE-4286-A72E-078B036A8B7DQ36558569-4F957714-9075-4F0E-85E6-556AAE351976Q36565841-86935AD1-58DB-47E4-AEF2-01B73F6A88A4Q36753048-98387A10-2B54-48BA-900A-F4F743349D9BQ36950326-B6D86EEF-07DE-47CD-9EC3-498BF5320982Q36987659-0C842E5D-CF7A-4ADB-9382-6F7C3E36B496Q37166723-29441058-12BF-4446-A93C-EC36DC575C64Q37200438-4F9DAB2C-28F6-49AB-8FE0-9A3A9D19ABEDQ37259815-24607A79-10AF-4493-9FCF-C4D374A9E915Q37338970-AA9331CC-9D76-4708-A7A3-34622CB456E2Q37355163-8DD5C31D-F228-4644-BEA3-F62DC975831CQ37389731-4E4763F4-6FA8-4BA3-A9C6-7B89F9912006
P2860
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@ast
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@en
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@nl
type
label
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@ast
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@en
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@nl
altLabel
SMARCB1/INI1Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas
@en
prefLabel
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@ast
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@en
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@nl
P2093
P1433
P1476
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
@en
P2093
Elena Lualdi
Federica Facchinetti
Lisa Galli
Piergiorgio Modena
Silvana Pilotti
P304
P356
10.1158/0008-5472.CAN-04-3050
P407
P577
2005-05-01T00:00:00Z